摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[L-alaninyl]-amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one Hydrochloride | 1055089-28-5

中文名称
——
中文别名
——
英文名称
5-[L-alaninyl]-amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one Hydrochloride
英文别名
(2S)-2-amino-N-(6-oxo-7H-benzo[d][1]benzazepin-5-yl)propanamide;hydrochloride
5-[L-alaninyl]-amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one Hydrochloride化学式
CAS
1055089-28-5
化学式
C17H17N3O2*ClH
mdl
——
分子量
331.802
InChiKey
YZAGLQRMIMUROF-MERQFXBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.04
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    75.4
  • 氢给体数:
    3
  • 氢受体数:
    3

文献信息

  • Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    申请人:——
    公开号:US20030149022A1
    公开(公告)日:2003-08-07
    Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    本发明涉及一种抑制β-淀粉样肽释放和/或其合成的化合物,因此在治疗阿尔茨海默病方面具有实用性。本发明还涉及包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物,以及使用这种药物组合物预防和治疗阿尔茨海默病的方法。
  • Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    申请人:——
    公开号:US20030162768A1
    公开(公告)日:2003-08-28
    Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    本发明涉及一种抑制β-淀粉样肽释放和/或其合成的化合物,因此具有治疗阿尔茨海默病的用途。还公开了包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物,以及使用这些药物组合物预防和治疗阿尔茨海默病的方法。
  • CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
    申请人:Elan Pharmaceuticals, Inc.
    公开号:EP1093372A1
    公开(公告)日:2001-04-25
  • EP1093372A4
    申请人:——
    公开号:EP1093372A4
    公开(公告)日:2004-09-29
  • US6528505B1
    申请人:——
    公开号:US6528505B1
    公开(公告)日:2003-03-04
查看更多